Ironwood Pharmaceuticals earnings were -$32.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IRWD earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$37.4M, down 1,757.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IRWD reported annual earnings of $880.0k, with -100.1% growth.
Ironwood Pharmaceuticals Earnings Reports & History FAQ
What were Ironwood Pharmaceuticals's earnings last quarter?
On IRWD's earnings call on Invalid Date, Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q1 2025 earnings per share (EPS) of -$0.23, up 666.67% year over year. Total IRWD earnings for the quarter were -$37.39 million. In the same quarter last year, Ironwood Pharmaceuticals's earnings per share (EPS) was -$0.03.
Is Ironwood Pharmaceuticals profitable or losing money?
As of the last Ironwood Pharmaceuticals earnings report, Ironwood Pharmaceuticals is currently losing money. Ironwood Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$32.34 million, a 96.93% decrease year over year.
What was IRWD's earnings growth in the past year?
As of Ironwood Pharmaceuticals's earnings date in Invalid Date, Ironwood Pharmaceuticals's earnings has grown year over year. IRWD earnings in the past year totalled -$32.34 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.